VP3,15 dihydrobromide

立即咨询

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

1281681-33-1

包装与价格：

包装	价格(元)
1mg	电议
5mg	电议

产品介绍

VP3.15 dihydrobromide 是高效、口服生物可利用的，CNS 可渗透的 PDE7-GSK3 双重抑制剂，对PDE7 和GSK3 作用的 IC50 值分别为 1.59 μM 和 0.88 μM。VP3.15 dihydrobromide 具有神经保护和神经修复活性，是多发性硬化症 (MS) 潜在的抗炎和促髓鞘再生联合治疗药物。

Cas No.	1281681-33-1
Canonical SMILES	[H]Br.[H]Br.N1(CC/N=C2N=C(C3=CC=CC=C3)N(C4=CC=CC=C4)S/2)CCOCC1
分子式	C₂₀H₂₄Br₂N₄OS
分子量	528.3
溶解度	DMSO: 62.5 mg/mL (118.30 mM)
储存条件	Store at -20°C
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
产品描述	VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 dihydrobromide has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS)[1]. IC50: 1.59 μM (PDE7), 0.88 μM (GSK-3)[1] [1]. Medina-RodrÍguez EM, et al. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis. Sci Rep. 2017 Mar 3;7:43545.